Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. (2nd August 2022)

• Record Type: Journal Article
• Authors: Kasitanon, Nuntana; Hamijoyo, Laniyati; Li, Meng Tao; Oku, Kenji; Navarra, Sandra; Tanaka, Yoshiya; Mok, Chi Chiu
• Is Part Of: International journal of rheumatic diseases. Volume 25:Number 11(2022)
• Page Start: 1220
• Page End: 1229
• Publication Date: 2022-08-02
• Subjects: lupus -- neuropsychiatric -- non‐renal -- prognosis -- severe; Rheumatology -- Periodicals; Rheumatology -- Asia -- Periodicals; Rheumatology -- Pacific Area -- Periodicals; Rheumatic Diseases -- Periodicals; Connective Tissue Diseases -- Periodicals; Immune System Diseases -- Periodicals; 616.723
• DOI: 10.1111/1756-185X.14413
• Languages: English
• ISSNs: 1756-1841

Abstract

Abstract: The prevalence of systemic lupus erythematosus (SLE) is higher in Asians than Caucasians, with higher frequency of renal and other major organ manifestations that carry a poorer prognosis. The outcome of SLE is still unsatisfactory in many parts of the Asia Pacific region due to limited access to healthcare systems, poor treatment adherence and adverse reactions to therapies. The Asia Pacific League of Associations for Rheumatology (APLAR) SLE special interest group has recently published a set of consensus recommendation statements for the management of SLE in the Asia Pacific region. The current article is a supplement of systematic literature search (SLR) to the prevalence and treatment of non‐renal manifestations of SLE in Asian patients.